The medicinal product has been authorised by the European Commission (EC) via centralised procedure in all EU Member States, based on the European Medicines Agency (EMA) experts' opinion.
Name
Ximluci
Active Substance
ranibizumab
Prescription
na recept
Type of prescription
ograničeni recept
Distribution
u ljekarni
ATC Code
S01LA04
Medicinal product marketed in the Croatia
Da
Summary of product characteristics (SmPC), labelling and package leaflet (PL)